Symmetric Bis-chalcones as a New Type of Breast Cancer Resistance Protein Inhibitors with a Mechanism Different from That of Chromones
摘要:
Potent ABCG2 inhibitors were recently identified as asymmetric chromones with different types of substituents. We here synthesized symmetric bis-chalcones that were differently substituted and screened for their ability to inhibit mitoxantrone efflux from ABCG2-transfected HEK293 cells. Potent bis-chalcone inhibitors were identified, the efficiency depending on both position of the central ketone groups and the number and positions of lateral methoxy substituents. The best derivative, namely, 1p, was selective for ABCG2 over P-glycoprotein and MRP1, appeared not to be transported by ABCG2, and was at least as active on various drug-selected cancer cells overexpressing ABCG2. Compound 1p stimulated the ABCG2 basal ATPase activity by contrast to a chromone lead that inhibited it, suggesting different mechanisms of interaction. Combination of both types of inhibitors produced synergistic effects, leading to complete inhibition at very low
This invention provides an organic electroluminescent element (organic EL element) utilizing phosphorescence which emits light efficiently with high luminance at low current density, shows good driving stability and is applicable to display devices such as flat panel displays and illuminating devices. The element comprises an anode, organic layers and a cathode piled one upon another on a substrate, at least one of the organic layers is a light-emitting layer containing a host material and a dopant material and a pyrazole-derived compound having 2-4 pyrazole structures represented by the following formula I in the same molecule is used as said host material;
wherein, Ar
1
-Ar
3
are independently hydrogen or substituted or unsubstituted aromatic hydrocarbon groups and at least one of Ar
1
-Ar
3
is a group other than hydrogen.